KN

KNOWLES CORP

Technology | Mid Cap

$0.15

EPS Forecast

$143

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-08-05

Knowles Corp’s Q2 2026 Runway: Knitting Revenue Gains Into a 2027 Growth Trajectory

Lede: KN, EPS, and the Revenue Forecast That Keeps On Giving

Knows as KN on the ticker tape, Knowles Corporation posted a standout second quarter for 2026, showcasing EPS momentum that arrived with a company-supplied sense of direction rather than a guess from the guidance goblins. The reported EPS for continuing operations came in at $0.21 on a GAAP basis, with a non-GAAP figure of $0.33, underscoring a real earnings surprise versus internal expectations. Management framed these results against a revenue backdrop that crossed the $166.8 million mark in Q2-26, marking a 14% year-over-year lift and reinforcing their revenue forecast for 2026 that contends with mid-teens growth in the late-stage cycle.

The company’s narrative centers on a diversified end-market mix—Medtech, Defense, Industrial, and Electrification—bolstered by a ramp in bookings and an improving backlog. Analysts looking for a clean consensus take may note that the filing doesn’t spell out a formal EPS consensus estimate from street estimates, but Knowles does project a robust trajectory for the back half of 2026 and into 2027.

Key Financial Highlights

  • Revenues: $166.8 million for Q2-26, up 14% year over year.
  • EPS (GAAP): $0.21 per share for continuing operations.
  • EPS (Non-GAAP): $0.33 per share, up 38% year over year.
  • Net cash from operations: $28 million in the quarter.
  • Operating momentum: Bookings rising across the portfolio, with a healthy backlog.

Management Commentary: A CEO’s Narrative That Hopes to Paint a Persistent Uptrend

In Ithaca-tinged words, the press release quotes Jeffrey Niew, Knowles’ President and CEO: the quarter delivered revenue above the guided range, with a non-GAAP EPS exceeding the top end of guidance. The tone is deliberate—there is no dramatic pivot, only a steady accrual of higher volumes across the Precision Devices segment. Niew highlights strength across Medtech, Defense, Industrial, and Electrification markets as proof that the company’s approach—leveraging unique technologies, deep customer intimacy, and scalable production—can translate into durable growth in a world of ongoing supply-chain friction.

The discussion of backlog and bookings is telling: Knowles notes “numerous new design wins ramping across multiple end markets” and suggests that the firm is entering a phase of repeatable demand rather than episodic spikes. The CEO’s stance on 2027 —expectation to exceed prior organic growth targets set at Knowles’ May 2025 Investor Day—reads as a vote of confidence in the company’s long-range portfolio and operational discipline.

Outlook and Forward Guidance: A Path Toward 2026 Revenue Growth and >20% EBITDA

Knowles reiterates a 2026 revenue trajectory of about 10–12% growth, paired with adjusted EBITDA expansion of more than 20%. The narrative emphasizes that cash generation remains a focus, with net cash from operations of $28 million in Q2-26, supporting ongoing investment in capacity, product development, and market expansion. Management’s outlook also hints at a longer horizon, where the company expects continued momentum in its end markets and a potential lift in margins as throughput improves and mix shifts toward higher-margin applications.

The company’s dateline—Itasca, Illinois—anchors a regional footprint and reinforces the domestic nature of its manufacturing cadence. While the press release avoids precise quarterly forecasts beyond 2026, the tone suggests a steady state of earnings power anchored by a balanced mix of medtech and industrial demand.

What This Could Mean for KN and Sector Peers

For KN holders and investors watching the components space, the quarter reads as a confirmation that Knowles’ diversified end-market exposure pays off in a period of macro uncertainty. A 14% revenue uptick, coupled with a non-GAAP EPS expansion well above the prior year, hints at a margin-friendly mix shift and disciplined cost management. The emphasis on a healthy backlog and rising bookings also signals resilience against cyclic downturns in any single end market.

Sector peers—RF filters, MEMS microphones, advanced microacoustics, and related passive components—could interpret Knowles’ performance as a sign that specialization, customer alignment, and scalable manufacturing remain viable routes to growth even when macro headwinds linger. If the company sustains its 2026 revenue forecast and achieves its >20% EBITDA growth target, the bar for peers may rise to demonstrate not just top-line strength but an accompanying improvement in cash generation and free cash flow.

The implied message for investors: the path from record bookings to realized profitability is not automatic, but Knowles’ execution suggests a template—one that favors a diversified product set, a rich backlog, and a disciplined approach to investment. In a world where end-market demand can be uneven, the ability to convert design wins into measurable operating leverage could become the differentiator among sector peers.

Key Takeaways

  • The KN Q2 2026 results reflect a meaningful earnings beat versus internal guidance, with EPS in non-GAAP terms of $0.33.
  • Revenue of $166.8 million marks a robust 14% YoY increase, underscoring the strength of the diversified end-market exposure.
  • Management remains focused on bookings, backlog health, and a multi-year growth trajectory that targets 2026 revenue growth of 10–12% and EBITDA expansion >20%.
  • The company’s outlook hinges on continued demand across Medtech, Defense, Industrial, and Electrification, plus a strong cash-generation profile.
  • Analysts’ EPS consensus for KN isn’t explicitly stated in the filing, but the reported figures sit above the company’s own guided ranges, creating a potential earnings surprise versus expectations.

Closing Thoughts: A Quiet Confidence, With An Eye on 2027

Knowles’ Q2 2026 narrative is not a one-off sprint; it’s a measured ascent anchored in a solid product mix and a backlog that looks less like a rumor and more like a runway. If the trajectory holds, sector peers with similar market exposure should be watching closely—not just for the numbers, but for how Knowles translates design wins into volume, volume into utilization, and utilization into cash flow. The bigger question for KN and its peers isn't whether growth will continue, but whether the industry has optimized its path to profitability once demand tightens.